Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
224,000+ research products · Triple ISO certified · COA & SDS available for every product · Same-day shipping on in-stock items
Why this grade
Moligand™, ≥95%, ~25mg/ml(in buffer,PH6.2) Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Storage & shipping
Protected from light,Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
Quality documents
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Literature proof
Cited in 2 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Overview
Bevacizumab is a humanized monoclonal antibody that binds to all VEGF-A with high affinity and specificity.
Specifications
Product Name
Bevacizumab (anti-VEGF) - Primary antibody
Synonyms
Anti-Human VEGF | Humanized Antibody | rhuMab VEGF, Avastin
Specifications & Purity
Moligand™, ≥95%, ~25mg/ml(in buffer, PH6.2)
Host species
Human
Grade
Moligand™
Action Type
INHIBITOR
Light Chain Type
kappa
Purification Method
Protein A purified
Concentration
~25mg/ml(in buffer, PH6.2)
CAS
216974-75-3
Storage and Shipping
Storage
Protected from light,Store at -20°C
Shipped In
Ice chest + Ice pads
Documentation
📋 Safety Data Sheet (SDS)
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →✅ Certificate of Analysis (COA)
Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →🔬 Specification Sheet
Full quality attributes and acceptance criteria for this grade.
View spec sheet →Advanced Data
Associated Targets(Human)
VEGFA Tclin Vascular endothelial growth factor A (0 Activities)
Certificates（CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 L2201667 | Certificate of Analysis | Sep 09, 2025 | B303060 |
| G2207118 | Certificate of Analysis | Apr 07, 2025 | B303060 |
| G2207121 | Certificate of Analysis | Apr 07, 2025 | B303060 |
| A2214365 | Certificate of Analysis | Nov 05, 2024 | B303060 |
| A2214366 | Certificate of Analysis | Nov 05, 2024 | B303060 |
| L2201633 | Certificate of Analysis | Aug 26, 2022 | B303060 |
Documents & Articles
Citations of This Product
References
| 1. Wenjuan Huang, Liwen Wang, Ruhui Yang, Ronggui Hu, Qinxiang Zheng, Xingjie Zan. (2022) Combined delivery of small molecule and protein drugs as synergistic therapeutics for treating corneal neovascularization by a one-pot coassembly strategy. Materials Today Bio, [PMID:36281304] [10.1016/j.mtbio.2022.100456] |
| 2. Yingchun Zeng, Jingxuan Yang, Ka Wang, Huan Xu, Yue Zheng, Songxin Guo, Jingwen Luo, Sha Liu, Xin Ming, Xue Ying. (2025) Multifunctional Polymeric Nanoparticles Codelivering Paclitaxel and Monoclonal Antibodies for Triple Combination Therapy of Colorectal Cancer. BIOMACROMOLECULES, [PMID:41246989] [10.1021/acs.biomac.5c01421] |
Solution Calculators
Reviews
Customer Reviews
Need help choosing the grade?
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Moligand™ grade guide →Remind me later
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
Copyright © 2023–present Aladdin Scientific Corp. All rights reserved.